Everything you need to know about Inventurus Knowledge Solutions IPO

About

Inventurus Knowledge Solutions Limited is a technology-enabled healthcare solutions provider focused on assisting outpatient and inpatient healthcare organizations across the US, Canada, and Australia. The platform empowers physicians to focus on patient care by handling administrative and operational tasks, improving efficiency, optimising revenue cycles, and supporting the transition to value-based care models. With 778 healthcare organisations as clients and a global workforce of over 13,500 employees, they deliver innovative solutions for better, safer, and cost-effective care. Their recent acquisition of Aquity Holdings enhances their capabilities in clinical documentation and inpatient care, enabling them to offer comprehensive healthcare solutions.

Issue size

Funds Raised in the IPO Amount
Overall ₹2497.92 crores
Offer for Sale ₹2497.92 crores

Financials

Financial Year Ended March 2022 March 2023 March 2024 September 2024
Total Assets 787.52 988.31 3,027.52 2,790.52
Revenue 784.47 1,060.16 1,857.94 1,294.61
Profit After Tax 232.97 305.23 370.49 208.58

Strengths

  • End-to-end solutions across outpatient and inpatient care.
  • Digital technologies driving sustained value and outcomes.
  • Strong brand with industry leadership and recognition.
  • 98% repeat client revenue over three years.
  • Scalable model offering cost savings and cross-selling.
  • Consistent growth and improving margins.
  • Experienced, entrepreneurial leadership.

Risks

  • Past FEMA issues may lead to penalties.
  • Ongoing litigation could harm our business.
  • Failure to develop AI solutions may hurt revenues.
  • Non-compliance with healthcare laws could result in penalties.
  • US healthcare challenges may impact our business.
  • Integration of Aquity Holdings could affect operations.

IPO schedule

Issue open date 2024-12-12
Issue close date 2024-12-16
UPI mandate deadline 2024-12-16 (5 PM)
Allotment finalization 2024-12-17
Refund initiation 2024-12-18
Share credit 2024-12-18
Listing date 2024-12-19
Mandate end date 2024-12-31
Lock-in end date for anchor investors (50%) 2025-01-16
Lock-in end date for anchor investors (remaining) 2025-03-17

GMP Tracker ^^^^

1 Like